New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 21, 2014
13:45 EDTCRM Earnings Preview: Analysts positive on Salesforce.com ahead of Q2 earnings
Salesforce.com (CRM) is expected to report second quarter earnings after the market close on Thursday, August 21 with a conference call scheduled for 5:00 pm ET. Salesforce.com is a provider of enterprise cloud computer and social enterprise solutions. EXPECTATIONS: Analysts are looking for earnings per share of 12c on revenue of $1.29B. The consensus range is 11c-13c for EPS, and $1.28B-$1.30B for revenue, according to First Call. LAST QUARTER: Salesforce.com reported first quarter EPS of 11c against estimates of 10c on revenue of $1.23B against estimates of $1.21B. Looking ahead, the company gave Q2 adjusted EPS guidance of 11c-12c and Q2 revenue of $1.29B. It also raised its full year 2015 EPS guidance to 49c-51c from 48c-50c, expecting 125bps-150bps of operating margin improvement during the year. Second quarter operating flow should grow approximately 10% year-over-year and FY15 operating cash flow should grow in the mid-20%. NEWS: Salesforce.com announced a strategic partnership with Microsoft to create new solutions that connect the company's customer relationship management apps and platform to Microsoft Office and Windows. Terms of the deal were not disclosed. Salesforce.com also announced a strategic alliances with Philips (PHG) and Deutsche Telekom's (DTEGY) customer unit T-Systems. In July, Salesforce.com agreed to acquire a relationship intelligence platform RelateIQ. The acquisition is expected to close in Q3 and not expected to have an impact on the company's guidance for revenue or non-GAAP EPS in FY15. STREET RESEARCH: UBS analysts said Salesforce.com remains one of its top large cap growth ideas, with international expansion opportunities and local data centers could open up pent-up demand and further accelerate growth. Ahead of the Q2 earnings, Pacific Crest believes the company's weakness is a buying opportunity after checks indicate transaction volumes are good enough to provide an uptick. BofA/Merrill analysts also recommends investors buy Salesforce.com heading into the second half given expectations for respectable billings and accelerating income growth. Oppenheimer expects the company to report good Q2 results with Q3 and second half of FY14 targets to exceed 25%. UBS, however, said Q2 results are expected to be uneventful although it sees a solid second half of the year. The firm cited its foundation for continued 20%+ revenue growth into next year with product extensions and increasing investments in Europe. PRICE ACTION: Salesforce.com shares have gained more than 4.4% since the first day of trading following the company's Q1 report. In Thursday afternoon trading ahead of the Q2 report, Salesforce.com shares are trading near the flat line at $55.38.
News For CRM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 28, 2015
16:00 EDTCRMFormer Salesforce CFO Graham Smith to depart June 30
Subscribe for More Information
12:47 EDTCRMTech sector earnings 'melt away' when accounting for stock comp, Barron's says
Subscribe for More Information
June 18, 2015
08:36 EDTCRMSalesforce price target raised to $80 from $75 at Baird
Subscribe for More Information
07:30 EDTCRMSalesforce initiatives should help social media companies, says Brean Capital
Subscribe for More Information
June 17, 2015
15:16 EDTCRMOptions with increasing volume
Subscribe for More Information
11:34 EDTCRMsalesforce.com calls active amid renewed takeover chatter
Subscribe for More Information
11:14 EDTCRMRumor: Salesforce spikes up amid renewed takeover chatter
Subscribe for More Information
10:00 EDTCRMOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AbbVie (ABBV) initiated with an Overweight at Piper Jaffray... Arista Networks (ANET) initiated with a Buy at Sterne Agee CRT... Astec (ASTE) initiated with a Buy at Maxim... Bristol-Myers (BMY) initiated with an Underweight at Piper Jaffray... Community Healthcare (CHCT) initiated with an Outperform at Oppenheimer... Eli Lilly (LLY) initiated with an Overweight at Piper Jaffray... Fitbit (FIT) initiated with a Buy ahead of IPO at Dougherty... Hortonworks (HDP) initiated with a Buy at Mizuho... II-VI (IIVI) initiated with a Buy at Benchmark Co.... J Sainsbury (JSAIY) initiated with an Underperform at Credit Suisse... McDermott (MDR) initiated with an Outperform at Cowen... Merck (MRK) initiated with a Neutral at Piper Jaffray... Molina Healthcare (MOH) initiated with a Buy at UBS... Pacific DataVision (PDVW) initiated with a Buy at Canaccord... Pfizer (PFE) initiated with an Overweight at Piper Jaffray... Quest Resource (QRHC) initiated with a Buy at Roth Capital... Regional Management (RM) initiated with a Buy at Janney Capital... Rofin-Sinar (RSTI) initiated with a Buy at Benchmark Co.... Salesforce (CRM) initiated with a Neutral at Exane BNP Paribas... Sprouts Farmers Markets (SFM) initiated with a Neutral at Cleveland Research... Tesco (TSCDY) initiated with an Underperform at Credit Suisse... WM Morrison (MRWSY) initiated with a Neutral at Credit Suisse... WWE (WWE) initiated with a Buy at BTIG... World Acceptance (WRLD) initiated with a Buy at Janney Capital... Zafgen (ZFGN) initiated with a Buy at SunTrust.
05:25 EDTCRMSalesforce initiated with a Neutral at Exane BNP Paribas
Target $81.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use